Research Article
Clinical and Renal Biopsy Findings Predicting Outcome in Renal Thrombotic Microangiopathy: A Large Cohort Study from a Single Institute in China
Table 4
Univariate renal survival analysis of patients with thrombotic microangiopathy.
| Parameters | HR | 95% CI | value | Lower | Upper |
| Age (years) | 0.982 | 0.956 | 1.009 | 0.196 | Gender (female versus male) | 0.319 | 0.169 | 0.602 | 0.001 | Serum creatinine score | 4.002 | 1.709 | 9.371 | 0.001 | Proteinuria (g/24 hr) | 0.991 | 0.920 | 1.068 | 0.820 | Plasma albumin value (g/L) | 0.994 | 0.952 | 1.037 | 0.765 | Hematuria | 1.327 | 0.777 | 2.265 | 0.301 | Hemoglobin score | 1.659 | 1.183 | 2.326 | 0.003 | Platelet score | 0.897 | 0.530 | 1.516 | 0.684 | Neurological involvement | 2.171 | 0.783 | 6.017 | 0.136 | Modified Rose score | 1.354 | 1.134 | 1.616 | 0.001 | Presence of acute renal TMA pathologic changes | 1.175 | 0.641 | 2.156 | 0.602 | Presence of chronic renal TMA pathologic changes | 2.709 | 1.327 | 5.532 | 0.006 | Isolated glomerular TMA pathologic changes | 0.232 | 0.057 | 0.953 | 0.043 | Isolated artery/arteriole TMA pathologic changes | 2.104 | 1.061 | 4.173 | 0.033 | Use of ACEI or ARB | 1.702 | 0.978 | 2.962 | 0.060 |
|
|
Notes: ACEI: angiotensin-converting enzyme inhibitors; ARB: angiotensin II receptor blockers.
|